Vimarsana
Biggest News Aggregation in the World

Page 4 - Lars Wegner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lars Wegner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lars Wegner Today - Breaking & Trending Today

Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award - Vimarsana News

Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award

Recognizes achievements in AI-enabled drug discoveryHighlights how Evaxion's platforms help to design novel immunotherapies efficiently COPENHAGEN, Denmark, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Evaxion

Investegate |Evaxion Biotech Announcements | Evaxion Biotech: Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award - Vimarsana News

Investegate |Evaxion Biotech Announcements | Evaxion Biotech: Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award

Investegate announcements from Evaxion Biotech, Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award

Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to ... - Vimarsana News

Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to ... Evaxion BiotechApril 20, 2021 GMT COPENHAGEN, Denmark, April 20, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today a presentation by Jens Kringelum, PhD, Evaxion...

Source: apnews.com
Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update - Vimarsana News

Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update Evaxion BiotechApril 6, 2021 GMT Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 million Clinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02 Cash reserves of $5.8 million at December 31, 2020 plus funds from IPO provide funding for at least 12 months from the date of completion of the...

Source: apnews.com
Evaxion Biotech Opens New Office and Laboratories to Support Future Growth - Vimarsana News

Evaxion Biotech Opens New Office and Laboratories to Support Future Growth

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com